The progress made to improve vaccination rates around the world is astounding, made possible through the cooperation and funding of many organizations, but much still needs to be done to decrease or eradicate vaccinepreventable diseases
To secure a federal grant, researchers must navigate a rigorous and long application process. But, when completed properly, those projects deemed most likely to have an impact on the nation’s health do get funded.
Today’s supply chain for blood and plasma products is safer than ever before, replete with stringent systems and safeguards to keep blood-borne diseases at bay.
With options ranging from new web-based applications to electronic medication reminders, physicians may need to think outside the pillbox when it comes to encouraging medication adherence.
A research scandal raises new questions about the safety of synthetic colloids in place of human albumin.
With the push to reduce the cost of healthcare yet improve the quality and efficiency of care, Accountable Care Organizations could be a solution.
The rising prevalence of skin cancer indicates many people don’t understand the risks of sun exposure and how they can protect themselves from this oftentimes deadly disease.
Several key variables play a role in the promising possibilities for lifesaving plasma protein therapies.
While these obscure, life-saving treatments are used to treat vastly different diseases, the common denominator they share is that each is made from plasma with a specialized high-titer antibody that provides short-term passive immunity.
Measles and mumps are rare diseases in the U.S. today due to greater immunity from a preventive vaccine, but these diseases still pose a real threat.
Diabetes is a full-blown epidemic in this country. But recent research is vastly changing our understanding of this life-threatening disease and providing new clues about how to treat and, possibly, even cure it.
Finally, there are more options for the unique bleeding disorder, von Willebrand disease.